Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jacobson Pharma Corporation Limited (2633) Stock Price & Analysis

7 Followers

2633 Stock Chart & Stats

HK$0.94HK$0.00(0.53%)
At close: 4:00 PM GMT+8
HK$0.95HK$1HK$1.05Aug 10Aug 24Sep 7Sep 21Oct 5Oct 20Nov 2
Day’s Range
HKD 0.93 - HKD 0.94
52-Week Range
HKD 0.93 - HKD 1.49
Previous Close
HKD 0.94
Volume
N/A
Average Volume (3M)
242.56K
Market Cap
HKD 1.78B
Enterprise Value
HKD 3.03B
Total Cash (Recent Filing)
HKD 369.86M
Total Debt (Recent Filing)
HKD 910.90M
Price to Earnings (P/E)
6.2
Beta
0.11
Next Earnings
Nov 20, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 07, 2026
Dividend Yield
9.62%

Bulls Say, Bears Say

Bulls Say

Strong Profitability

Strong gross and net margins indicate that Jacobson Pharma is converting sales into meaningful earnings, supporting internal funding for product development, manufacturing, and distribution. Improved profitability versus earlier years also suggests stronger earnings power and a more resilient operating model over the next several quarters.

Improved Leverage And Returns

Lower leverage reduces financial pressure and improves the company’s capacity to withstand operating volatility or invest in growth. At the same time, rising ROE indicates better use of shareholder capital, strengthening the quality of Jacobson Pharma’s financial profile over the medium term.

Positive Operating Cash Generation

Positive operating and free cash flow provide an important foundation for funding operations, product activity, and capital needs without relying entirely on external financing. Although recent momentum weakened, the continued positive cash generation supports financial resilience and ongoing business continuity.

Bears Say

Revenue Growth Volatility

Volatile revenue performance makes future earnings less predictable and indicates that the company has not yet established a consistently expanding growth trajectory. Modest latest-period growth may limit operating leverage, reduce visibility for reinvestment, and make margin progress harder to sustain.

Declining Free Cash Flow

A material free-cash-flow decline can reduce the funds available for product development, debt reduction, dividends, or strategic investment even when accounting profits remain strong. Choppy cash generation also makes capital allocation less predictable and weakens confidence in earnings conversion.

Reduced Balance-Sheet Flexibility

Although leverage has improved, higher absolute debt alongside a smaller asset and equity base modestly reduces financial flexibility compared with the prior peak. This could constrain the company’s ability to absorb weaker trading conditions or fund sizeable strategic initiatives internally.

Jacobson Pharma Corporation Limited News

2633 FAQ

What was Jacobson Pharma Corporation Limited’s price range in the past 12 months?
Jacobson Pharma Corporation Limited lowest stock price was HK$0.93 and its highest was HK$1.49 in the past 12 months.
What is Jacobson Pharma Corporation Limited’s market cap?
Jacobson Pharma Corporation Limited’s market cap is HK$1.78B.
When is Jacobson Pharma Corporation Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jacobson Pharma Corporation Limited’s earnings last quarter?
Jacobson Pharma Corporation Limited released its earnings results on Jun 23, 2026. The company reported HK$0.08 earnings per share for the quarter.
Is Jacobson Pharma Corporation Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Jacobson Pharma Corporation Limited pay dividends?
Jacobson Pharma Corporation Limited pays a Semiannually dividend of HK$0.048 which represents an annual dividend yield of 9.62%. See more information on Jacobson Pharma Corporation Limited dividends here
What is Jacobson Pharma Corporation Limited’s EPS estimate?
Jacobson Pharma Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jacobson Pharma Corporation Limited have?
Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding.
What happened to Jacobson Pharma Corporation Limited’s price movement after its last earnings report?
Jacobson Pharma Corporation Limited reported an EPS of HK$0.08 in its last earnings report. Following the earnings report the stock price went down -2.762%.
Which hedge fund is a major shareholder of Jacobson Pharma Corporation Limited?
Currently, no hedge funds are holding shares in HK:2633
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology